Viewing Study NCT04510493


Ignite Creation Date: 2025-12-25 @ 1:07 AM
Ignite Modification Date: 2025-12-25 @ 11:19 PM
Study NCT ID: NCT04510493
Status: COMPLETED
Last Update Posted: 2021-09-08
First Post: 2020-08-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Canakinumab in Patients With COVID-19 and Type 2 Diabetes
Sponsor: University Hospital, Basel, Switzerland
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module